Carol Wilkinson, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electroencephalography | 7 | 2024 | 6189 | 1.300 |
Why?
|
Child Language | 1 | 2021 | 62 | 0.730 |
Why?
|
Fragile X Syndrome | 1 | 2021 | 116 | 0.670 |
Why?
|
Language Development | 2 | 2021 | 181 | 0.640 |
Why?
|
Observation | 1 | 2019 | 312 | 0.590 |
Why?
|
Down Syndrome | 1 | 2024 | 892 | 0.530 |
Why?
|
Brain | 7 | 2024 | 26951 | 0.460 |
Why?
|
Checklist | 1 | 2019 | 827 | 0.410 |
Why?
|
Child Development | 2 | 2024 | 2285 | 0.400 |
Why?
|
Cytoskeletal Proteins | 4 | 2013 | 1343 | 0.390 |
Why?
|
Developmental Disabilities | 1 | 2019 | 1504 | 0.360 |
Why?
|
Siblings | 2 | 2024 | 824 | 0.300 |
Why?
|
Cognition | 2 | 2023 | 6957 | 0.270 |
Why?
|
Receptors, AMPA | 3 | 2013 | 323 | 0.260 |
Why?
|
Infant | 10 | 2024 | 36060 | 0.250 |
Why?
|
Nerve Tissue Proteins | 4 | 2013 | 4407 | 0.240 |
Why?
|
Child, Preschool | 8 | 2024 | 42063 | 0.230 |
Why?
|
Pediatrics | 1 | 2019 | 3586 | 0.230 |
Why?
|
Beta Rhythm | 1 | 2024 | 63 | 0.230 |
Why?
|
Alpha Rhythm | 1 | 2024 | 109 | 0.230 |
Why?
|
Theta Rhythm | 1 | 2024 | 217 | 0.210 |
Why?
|
Autistic Disorder | 2 | 2021 | 1216 | 0.200 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2021 | 116 | 0.180 |
Why?
|
Brain Waves | 1 | 2024 | 401 | 0.180 |
Why?
|
Neuronal Plasticity | 4 | 2013 | 1430 | 0.170 |
Why?
|
Event-Related Potentials, P300 | 1 | 2021 | 149 | 0.170 |
Why?
|
Serum Response Factor | 1 | 2009 | 78 | 0.160 |
Why?
|
Thalamus | 1 | 2024 | 1041 | 0.150 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14495 | 0.150 |
Why?
|
Immediate-Early Proteins | 1 | 2009 | 449 | 0.130 |
Why?
|
RNA Stability | 1 | 2007 | 333 | 0.120 |
Why?
|
Language Development Disorders | 1 | 2016 | 192 | 0.120 |
Why?
|
Income | 1 | 2023 | 1875 | 0.120 |
Why?
|
Anesthesia | 1 | 2024 | 1584 | 0.110 |
Why?
|
Mothers | 1 | 2023 | 2186 | 0.100 |
Why?
|
Central Nervous System Stimulants | 1 | 2021 | 1174 | 0.100 |
Why?
|
Recurrence | 1 | 2024 | 8482 | 0.100 |
Why?
|
Synapses | 1 | 2010 | 1757 | 0.090 |
Why?
|
Sex Factors | 2 | 2024 | 10547 | 0.080 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7806 | 0.080 |
Why?
|
Program Evaluation | 1 | 2016 | 2493 | 0.070 |
Why?
|
Humans | 14 | 2024 | 760621 | 0.070 |
Why?
|
Male | 8 | 2024 | 359744 | 0.070 |
Why?
|
Risk | 1 | 2019 | 9631 | 0.070 |
Why?
|
Parents | 2 | 2021 | 3549 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 3701 | 0.060 |
Why?
|
Child | 4 | 2023 | 79806 | 0.060 |
Why?
|
Bicuculline | 2 | 2013 | 96 | 0.060 |
Why?
|
Prospective Studies | 4 | 2024 | 54303 | 0.060 |
Why?
|
Health Promotion | 1 | 2016 | 2206 | 0.060 |
Why?
|
Cell Nucleus | 1 | 2013 | 2907 | 0.060 |
Why?
|
Neurons | 3 | 2013 | 9426 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 8035 | 0.060 |
Why?
|
Gene Expression | 1 | 2006 | 7588 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 11903 | 0.050 |
Why?
|
Female | 6 | 2024 | 391270 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2007 | 12766 | 0.050 |
Why?
|
Homeostasis | 1 | 2013 | 3306 | 0.050 |
Why?
|
Neuropeptide Y | 1 | 2010 | 191 | 0.040 |
Why?
|
Transcription Factors | 1 | 2009 | 12103 | 0.040 |
Why?
|
Telemedicine | 1 | 2016 | 3018 | 0.040 |
Why?
|
PC12 Cells | 1 | 2009 | 317 | 0.040 |
Why?
|
AIDS-Related Complex | 1 | 2007 | 107 | 0.040 |
Why?
|
San Francisco | 1 | 2016 | 162 | 0.030 |
Why?
|
GABA Antagonists | 1 | 2006 | 120 | 0.030 |
Why?
|
Rats | 3 | 2013 | 23711 | 0.030 |
Why?
|
Evoked Potentials | 1 | 2022 | 1036 | 0.030 |
Why?
|
Blotting, Northern | 1 | 2006 | 1543 | 0.030 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2006 | 448 | 0.030 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2013 | 60 | 0.030 |
Why?
|
Nuclear Localization Signals | 1 | 2013 | 77 | 0.030 |
Why?
|
Rats, Long-Evans | 1 | 2013 | 378 | 0.030 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2006 | 599 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 2006 | 1900 | 0.030 |
Why?
|
Language | 1 | 2021 | 1533 | 0.030 |
Why?
|
Tetrodotoxin | 1 | 2013 | 246 | 0.030 |
Why?
|
beta-Galactosidase | 1 | 2013 | 575 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2009 | 18957 | 0.020 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2013 | 369 | 0.020 |
Why?
|
Drug Interactions | 1 | 2006 | 1428 | 0.020 |
Why?
|
Memory | 1 | 2010 | 2179 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2006 | 2672 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2013 | 586 | 0.020 |
Why?
|
Blotting, Western | 1 | 2006 | 5039 | 0.020 |
Why?
|
Animals | 5 | 2013 | 167963 | 0.020 |
Why?
|
Transfection | 1 | 2006 | 5781 | 0.020 |
Why?
|
Base Sequence | 1 | 2009 | 12446 | 0.020 |
Why?
|
Communication | 1 | 2022 | 3849 | 0.020 |
Why?
|
Protein Transport | 1 | 2013 | 1964 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2013 | 1674 | 0.020 |
Why?
|
Models, Molecular | 1 | 2007 | 5434 | 0.020 |
Why?
|
Mice | 3 | 2013 | 81208 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2009 | 17624 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3726 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2010 | 14372 | 0.020 |
Why?
|
Pilot Projects | 1 | 2016 | 8555 | 0.010 |
Why?
|
Calcium | 1 | 2006 | 5725 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11071 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 65017 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29749 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9530 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 41335 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2022 | 17790 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2006 | 5761 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7850 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22023 | 0.010 |
Why?
|
Mutation | 1 | 2013 | 29932 | 0.000 |
Why?
|
Adult | 1 | 2016 | 219994 | 0.000 |
Why?
|